Neuropsychological assessment can prove tremendously useful in evaluating an individual’s key cognitive skills. We assess a variety of skills to build up a comprehensive picture, including memory, attention, concentration, executive functioning (planning, reasoning), general intelligence, processing speed, verbal comprehension, and perceptual skills, as well as standardized neuropsychiatric evaluation.
Our group conducts comprehensive neuropsychological assessments across a broad range of neurological populations, including patients with Parkinson’s disease (PD), Alzheimer’s disease (AD), multiple sclerosis (MS), chronic migraine, and spinocerebellar ataxia (SCA). These evaluations are tailored to the specific cognitive and neuropsychiatric profiles associated with each condition, allowing us to characterize domain-specific impairments, monitor disease progression, and assess the cognitive effects of pharmacological and neuromodulatory interventions. The longitudinal application of these assessments in our patient cohorts has enabled us to identify sensitive markers of cognitive decline and treatment response across different neurological disorders.
We also have extensive experience using specialized software and programming environments — including E-Prime and Psychotoolbox— to design and implement experimental paradigms and computerized cognitive tests, allowing for precise stimulus control and automated data collection within both research and clinical settings